Although the function of T cells is eventually exhausted by PD-L1 in the tumor microenvironment, the significantly increased baseline number of T cells results in a significant increase in the number of T cells that regain activity after anti-PD-L1 treatment191,192. This evidence concerns the gene CD274 and neoplasm.